Subsequent studies revealed its role in inhibiting bone formation by regulating ATF4 [32] and promoting hepatic stellate cell activation by suppressing Sufu expression in non-alcoholic steatohepatitis [33], and so on. This evidence concerns the gene SUFU and metabolic dysfunction-associated steatohepatitis.